Pamela Lapham

Vice President of Regulatory Affairs, Thymmune Therapeutics

Role
Vice President of Regulatory Affairs at Thymmune Therapeutics
Location
Cambridge, MA, US
LinkedIn followers
500 followers

About Pamela Lapham

Highly accomplished Regulatory Affairs professional with over 30 years experience spanning translational medicine through pivotal clinical trials-Expert in managing US FDA and EU submissions for a wide range of products, including cell and gene therapies, vaccines, antibodies, small molecule drugs, medical devices, and combinationproducts leveraging novel drug delivery systems-Adept at guiding successful regulatory and quality strategies for complex investigational products across diverse indications-Proven track record for acquiring Orphan Drug and accelerated program designations to facilitate rapid product approval pathways. Core Expertise: Extensive experience with US FDA (CBER, CDER, CDRH) and EU (EMA) regulations, with a focus on IND/IDE strategy, nonclinical and CMC modules, and protocol/ ICF/ DSUR/ CSR authoring. Key Accomplishments: Demonstrated success in securing FDA product clearances, approvals, and designations through a deep understanding of regulatory strategy, clinical execution, andquality management; managed and/or contributed to the successful acquisition of over $10M in grant funding. Publications & Presentations: Primary and/or contributing author on 25 peer-reviewed scientific publications /book chapters and 60+ scientific abstracts and presentations. Broad Experience: Proficient in applying US FDA 21 CFR, EU CTR 536/2014, and MDR/IVDR regulations, and served as a primary liaison and trusted partner for top-tier clients including Abbott, Alnylam, Eli Lilly, Exact Sciences, Novo Nordisk, Otsuka, Regeneron, Sanofi, and the US Department of Defense.

Experience

  1. Vice President of Regulatory Affairs

    Thymmune Therapeutics

    Oct 2024 — Present · Cambridge, MA, US

    Provides strategic guidance and comprehensive regulatory strategies across nonclinical, CMC, and clinical activities, with a primary focus on thymic-related disorders- Strategizes, leads, writes, and supervises the development and submission of documents or plans to regulatory agencies to support development goals- Serves as the primary point of contact for global regulatory authorities, leading all communications and meetings- Drives profitability and growth of Thymmune by supporting commercial teams in the development and expansion of clinical indications for innovative iPSC-derived products- As a member of the Thymmune Leadership Team, contributes to companystrategy and operations to foster a culture of excellence and continuous improvement.

Education

  • San Diego State University

    Advanced Certification, Regulatory Affairs

    2007 — 2007

  • University of Massachusetts Dartmouth

    Bachelor of Science (BS), Biology, General

    1982 — 1986

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Pamela Lapham — Vice President of Regulatory Affairs at Thymmune Therapeutics in Cambridge, MA, US | Unifers